KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 76 filers reported holding KURA ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $63,000 | -95.9% | 2,218 | -94.6% | 0.00% | -100.0% |
| Q4 2020 | $1,536,000 | +15.9% | 41,188 | -3.2% | 0.00% | 0.0% |
| Q3 2020 | $1,325,000 | +105.1% | 42,534 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $646,000 | +864.2% | 36,118 | +646.5% | 0.00% | – |
| Q4 2019 | $67,000 | +45.7% | 4,838 | +60.7% | 0.00% | – |
| Q3 2019 | $46,000 | -6.1% | 3,010 | +22.1% | 0.00% | – |
| Q2 2019 | $49,000 | – | 2,465 | +82066.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.2% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 400 | +105.1% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 195 | +10.8% | 0.00% | – |
| Q2 2018 | $3,000 | -97.9% | 176 | -97.7% | 0.00% | – |
| Q1 2018 | $144,000 | -4.0% | 7,636 | -22.4% | 0.00% | – |
| Q4 2017 | $150,000 | -97.5% | 9,834 | -97.6% | 0.00% | -100.0% |
| Q3 2017 | $6,018,000 | – | 402,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |